首页> 外国专利> Composition of the treatment of vascular diseases or KCa3.1 channel-mediated diseases comprising modafinil or derivatives thereof

Composition of the treatment of vascular diseases or KCa3.1 channel-mediated diseases comprising modafinil or derivatives thereof

机译:包含莫达非尼或其衍生物的血管疾病或KCa3.1通道介导的疾病的治疗组合物

摘要

The present invention relates to modafinil or derivatives thereof as a medicine for the treatment of vascular diseases or KCa3.1 channel (Ca activated K channel) mediated diseases and a novel use of the same. More specifically, the present invention relates to a pharmaceutical composition for the prevention or treatment of vascular diseases or KCa3.1 channel-mediated diseases comprising modafinil or a derivative of modafinil, or pharmaceutically acceptable salts thereof which relax blood vessels and inhibit KCa3.1 channel currents by increasing intracellular cAMP, a method for treating vascular diseases or KCa3.1 channel-mediated diseases using the composition and a health functional food composition for the prevention or improvement of vascular diseases or the KCa3.1 channel-mediated diseases comprising modafinil or a modafinil derivative compound, or sitologically acceptable salts thereof.
机译:本发明涉及莫达非尼或其衍生物,其作为用于治疗血管疾病或KCa3.1通道(Ca激活的K通道)介导的疾病的药物及其新用途。更具体地,本发明涉及用于预防或治疗血管疾病或KCa3.1通道介导的疾病的药物组合物,该药物组合物包含莫达非尼或莫达非尼的衍生物或其药学上可接受的盐,其松弛血管并抑制KCa3.1通道。通过增加细胞内cAMP的电流,使用该组合物治疗血管疾病或KCa3.1通道介导的疾病的方法和用于预防或改善血管疾病或KCa3.1通道介导的疾病的保健功能食品组合物,所述药物包括莫达非尼或莫达非尼衍生物化合物或其在学上可接受的盐。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号